(Press-News.org) Using a complex modeling program that helps analyze the physical dynamics of large, structurally complex protein molecules, a research team has made progress towards finding a weak spot in the architecture of a group of enzymes that are essential to antibiotic resistance in a number of bacteria.
In an article published in PLOS ONE, University of North Carolina at Charlotte senior biology major Jenna R. Brown and her faculty mentor, UNC Charlotte professor of bioinformatics and genomics Dennis R. Livesay, present an analysis of the four currently known protein structures of the class C beta-lactamase enzymes - molecular machines that have evolved to allow bacteria to dismantle a variety of antibiotic molecules, including third generation cephalosporins.
The researchers find that all four molecules are remarkably similar in having a rigid protein superstructure, but with three "flexible" structural elements at the active site - the part of the enzyme that acts on the antibiotic. The analysis shows that the flexible structures are "cooperatively correlated" in their motions - the movements of the molecular segments are linked and the linkage is similar in all four molecules analyzed.
The researchers say that the unusual close similarity of the dynamical properties - the way the coupled dynamics within the active site loops is been preserved by the evolutionary process in four different bacterial groups - and the fact that the conserved correlated flexibility happens at the active site implies that this specific structural feature is critical to its advanced antibacterial properties.
"From an evolutionary perspective, this is really cool," Livesay said. "Here's a protein that has a very intense set of evolutionary pressures on it, making these couplings critical and not allowing them to vary. We've never seen that before. Typically these couplings are quite variable, even when they are otherwise closely related enzymes."
"Clearly this result is important because it is at the active site, because it is evolutionarily conserved, and because we have never seen this degree of conservation in any other system before," Livesay noted.
The analysis was done using the Distance Constraint Model (DCM), a protein analysis program developed by Livesay and UNC Charlotte biophysicist Donald Jacobs that allows relatively detailed but also relatively streamlined comparison of the properties and behaviors of complex protein structures based on their sequence of amino acids.
The DCM's efficient but accurate structural analysis allowed the researchers to make complex structural comparisons between many different (but related) protein molecules in realistic computing timescales that would be inaccessible by traditional methods. The DCM allows researchers to quickly and accurately pinpoint specific differences in dynamical properties between the structures, such as differing amounts of rigidity/flexibility in specific parts of the protein's complex structure.
In a previous study using the DCM to analyze a related class of beta-lactamase enzymes, Livesay and Jacobs found evolutionary changes in the structure of the enzyme had no relation to the specific antibiotics the enzyme was effective in dismantling. The researchers, however, did find that the overall structure of these class A beta-lactamase enzymes was unusually rigid.
The overall stability of the beta-lactamase protein, the authors of the previous study suspected, allowed changes in the components of the active site to evolve easily and rapidly because most changes there would not disrupt the more general characteristics of the protein. Beta-lactamase's ability to almost endlessly evolve the structure of its active site without other consequences perhaps accounts for beta-lactamase's ability to rapidly evolve in response to new antibiotics.
The earlier finding was discouraging for medicine because it meant that there were probably few (if any) opportunities to disable class A enzymes by bonding small molecules to the proteins and changing their enzymatic activity through allosteric effects - the active site was apparently unaffected by changes in other parts of the protein structure. However, the current finding regarding the linked, flexible structural components of class-C beta lactamases may be a very different story.
"We have strong evidence from our past research that allostery - dynamic connections between different structural components in a large molecule - is very sensitive to disruption," Livesay noted. "And we have seen here that these coupled elements at class C active sites are highly conserved by evolution, probably for a good reason related to function. If you were able to disrupt that coupling, there is a good likelihood that you would have a nice therapeutic effect."
While his lab does not do drug discovery, Livesay says the finding points to where labs that do such research ought to look.
"From a therapeutic point of view, you can imagine that if you could create a small molecule that bound to the active site somewhere else, it could decouple active site loop dynamics, and you would disable something vital to the enzyme," he said.
Theoretically, adding such a molecule to antibiotics that class C beta-lactamases usually disable would make them effective again against drug resistant bacteria, Livesay speculated.
Livesay's lab continues to work on analyzing other classes of beta-lactamase in the hope that understanding the complex structural dynamics of the enzyme will reveal its functional limits and its weaknesses. Paraphrasing a famous quote by Theodosius Dobzhansky regarding evolution, Livesay remarked: "Nothing in biology makes sense except in the light of biophysics."
INFORMATION:
The paper is available online at http://dx.plos.org/10.1371/journal.pone.0125832 . Jenna Brown, the first author on the paper, won best Natural Sciences and Public Health poster at UNC Charlotte's 2014 Summer Research Symposium and first place in the Bioinformatics division at the 2015 Undergraduate Research Conference for her presentations of this work.
Immune cells play an important role in the upkeep and repair of our bodies, helping us to defend against infection and disease. Until now, how these cells detect a wounded or damaged site has largely remained a mystery. New research, led by University of Bristol academics in collaboration with a team from the University of Sheffield, has identified the triggers which lead these cells to react and respond in cell repair.
It is hoped the findings, published in Current Biology, could help scientists design therapies to manipulate the cell repair process and direct immune ...
Flies might be smarter than you think. According to research reported in the Cell Press journal Current Biology on May 28, fruit flies know what time of day it is. What's more, the insects can learn to connect different scents with the sweet reward of sugar, depending on the hour: menthol in the morning and mushrooms in the afternoon.
Researchers say that the findings show the surprising mental abilities of animals, no matter how small.
"If even the fly, with its miniature brain, has the sense of time, most animals may have it," says Martin Heisenberg of Rudolf Virchow ...
Controlling bacterial infections responsible for typhoid fever could dramatically reduce the risk of gallbladder cancer in India and Pakistan, according to a study published by Cell Press May 28th in Cell Host & Microbe. The findings establish for the first time the causal link between bacterial infection and gallbladder cancer, explaining why this type of cancer is rare in the West but common in India and Pakistan, where typhoid fever is endemic. Public policy changes inspired by this research could have an immediate impact on preventing a type of cancer that currently ...
The chemical rapamycin is used clinically as an immunosuppressant and as an anti-cancer agent that works by inactivating a protein named TOR (Target Of Rapamycin). This protein is essential for the growth of normal cells, but is hyperactive in tumor cells. To be able to carry out its various growth-related tasks, TOR needs to assemble into one of two larger protein complexes named TORC1 and TORC2. Curiously, whereas TORC1 is inhibited by rapamycin, TORC2 is unaffected by this drug. The team of Robbie Loewith, professor in biology at the University of Geneva (UNIGE), Switzerland, ...
DURHAM, N.C. -- Duke Medicine researchers have found that bladder cells have a highly effective way to combat E. coli bacteria that cause urinary tract infections (UTIs).
In a study published online May 28, 2015, in the journal Cell, Duke researchers and their colleagues describe how bladder cells can physically eject the UTI-causing bacteria that manage to invade the host cell.
This response is analogous to having indigestion and vomiting to rid the stomach of harmful substances.
The finding suggests there may be a potential way to capitalize on this natural tendency ...
New research suggests that European and Asian (Eurasian) peoples originated when early Africans moved north - through the region that is now Egypt - to expand into the rest of the world. The findings, published in the American Journal of Human Genetics, answer a long-standing question as to whether early humans emerged from Africa by a route via Egypt, or via Ethiopia.
The extensive public catalogue of the genetic diversity in Ethiopian and Egyptian populations developed for the project also now provides a valuable, freely available, reference panel for future medical ...
CAMBRIDGE, MA -- Some decisions arouse far more anxiety than others. Among the most anxiety-provoking are those that involve options with both positive and negative elements, such choosing to take a higher-paying job in a city far from family and friends, versus choosing to stay put with less pay.
MIT researchers have now identified a neural circuit that appears to underlie decision-making in this type of situation, which is known as approach-avoidance conflict. The findings could help researchers to discover new ways to treat psychiatric disorders that feature impaired ...
La Jolla, Calif., May 28, 2015 - A new collaborative study led by researchers at Sanford-Burnham Medical Research Institute (Sanford-Burnham), published today in Cell Reports, provides new insight into the molecular changes that lead to resistance to a commonly prescribed group of drugs called BRAF inhibitors. The findings suggest that targeting newly discovered pathways could be an effective approach to improving the clinical outcome of patients with BRAF inhibitor-resistant melanoma tumors.
Melanoma is the deadliest form of skin cancer, killing more than 8,000 people ...
This news release is available in French.
One night of poor sleep significantly decreases performance on intelligence tests in children with autism spectrum disorder (ASD) and also in neurotypical children (without ASD). This is the conclusion made by researchers at the Hôpital Rivière-des-Prairies, affiliated with the Institut universitaire en santé mentale de Montréal and Université de Montréal.
For a paper published in the International Journal of Psychophysiology, the researchers observed the EEG measures of 13 autistic children ...
Ex-prisoners with a history of risky drug use, mental illness or poverty are more likely to end up back behind bars. Those who are obese, are chronically ill or have attempted suicide are more likely to remain in the community. These are some of the findings from an exploratory study into health-related factors that could be used to predict whether a person released from prison will end up in custody again. It was led by Emma Thomas of the University of Melbourne in Australia and is published in Springer's journal Health & Justice, an open access journal.
In many countries, ...
